A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: High and low serum thiocyanate groups as an indication of smoking

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 191-202

  Botti, Torey P ^a   Amin, Hetal ^a   Hiltscher, Laura ^a   Wissler, Robert W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Lipid and apo E extent; M numbers; PDAY; Risk factors

Indexed keywords

APOLIPOPROTEIN E; THIOCYANATE;

ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0030565016     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05825-X     Document Type: Article

References (23)

1. [1] Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9(Suppl I):I-19-I-32.
2. [2] Wissler RW, Komatsu A, Ko C, Kusumi Y. Vesselinovitch D. The cell populations and other components of the atheromatous lesion in young people. In: Hauss WH, Wissler RW. Bauch H-J. (eds). New aspects of metabolism and behavior of mesenchymal cells during the pathogenesis of atherosclerosis. Opladen: Westdeutscher Verlag, 1991;49-60.
3. [3] Stein Y. Smoking and coronary heart disease: are lipoproteins the link? Lipid Rev 1992:6:9-16.
4. [4] Goldstein JL, Brown MS. The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977;46:897-930.
5. [5] Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 1979;76:333-337.
6. [6] Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:915-922.
7. [7] Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994;108(Suppl.):S21-S29.
8. [8] Wissler RW. New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Atherosclerosis 1994:108(Suppl):S3-S20.
9. [9] Oyer CE, Berger B, Wissler RW and the PDAY Research Group. Evidence for more extensive deposits of epitopes of oxidized low density lipoprotein in aortas of young people with elevated serum thiocyanate levels. Atherosclerosis 1996;121:23-33.
10. [10] Wissler RW, Hiltscher L, Wahden M. Early evolution of coronary artery lesions in young people: from fatty streak to fibrous plaque-implications for imaging. In: Fuster V (ed.). Syndromes of athersclerosis: Correlation of clinical imaging and pathology. Armonk: Futura Publishing Co. 1996: 65-80
11. [11] Getz GS, Mazzone T, Soltys P, Bates SR. Atherosclerosis and apoprotein E: An enigmatic relationship. Arch Pathol Lab Med. 1988;112:1048-1055.
12. [12] Keidar S, Kaplan M, Rosenblat M, Brook GJ, Aviram M. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low density lipoproteins (VLDL), but increase cellular degradation of native VLDL. Metabolism 1992;41:1185-1192.
13. [13] Rubin EM, Verstuyft JG, Walsh A, Aalto-Setaia K, Hayek T, Smith JD, Plump AS. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E deficient mice created by homologous recombinations in ES cells. Cell 1992;10:343-353.
14. [14] Wissler RW. USA multicenter study of the pathobiological determinants of atherosclerosis in youth. Ann NY Acad Sci 1991;623:26-39.
15. [15] Wissler RW. Fredrickson Award Lecture: The PDAY study in perspective. In: Woodford FP, Davignon J, Sniderman J (eds). Atherosclerosis X. Amsterdam: Elsevier 1995;30-39.
16. [16] Strong JP, Oalmann MC, Malcom GT and the PDAY Research Group. Pathobiological determinants of atherosclerosis in youth: rationale, methodology, and selected risk factor findings. Cardiovasc Risk Factors 1992;2:22-30.
17. [17] Tracy RE. Quantitative measures of the severity of hypertensive nephrosclerosis. Am J Epidemiol 1970;91:25-31.
18. [18] Wissler RW. Quantitative microscopic morphometry of the major components of the atherosclerotic plaque. In: Wissler RW, Bond MG, Mercuri M, Tanganelli P, Weber G, Friedman G (eds). Atherosclerotic plaques: advances in imaging for sequential quantitative evaluation. New York: Plenum Press 1991;205-212.
19. [19] Wissler RW, Hiltscher L, Oinuma T and the PDAY Research Group. The lesions of atheroclerosis in the young: from fatty streaks to intermediate lesions. In: Fuster V, Ross R, Topol EJ (eds). Atherosclerosis and coronary artery disease. New York: Lippincott-Raven Press 1995;475-489 and colorplates 12-16.
20. [20] Parthasarathy S, Steinberg D, Witztum J. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 1992;43:219-225.
21. [21] Steinberg D, Witztum JL. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792.
22. [22] Wissler RW. Important points in the pathogenesis of atherosclerois. In: Gotto AM Jr (ed.). Atherosclerosis. Kalamazoo, MI: The Upjohn Company 1992;51-88.
23. [23] Babaev VR. Localization of apolipoprotein E in normal and atherosclerotic human aorta. Atherosclerosis 1990;85:239-247.